awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36385800-77CA1C3C-2B7A-4A2D-A5AF-2C858D6D6877
Q36385800-77CA1C3C-2B7A-4A2D-A5AF-2C858D6D6877
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36385800-77CA1C3C-2B7A-4A2D-A5AF-2C858D6D6877
Multi-parametric analysis reveals enhanced G2-phase arrest of an optimized anti-HER2 antibody to inhibit breast cancer.
P2860
Q36385800-77CA1C3C-2B7A-4A2D-A5AF-2C858D6D6877
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36385800-77CA1C3C-2B7A-4A2D-A5AF-2C858D6D6877
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dcd0f17c0decb2a677a3d4a0ab1ae2f32ed0b0bb
P2860
Pertuzumab: a new anti-HER2 drug in the management of women with breast cancer.